Dr. Ebele Mary-Anne Umeukeje, MD

Dr. Umeukeje practices at Vanderbilt Dialysis Clinic in Nashville, Tennessee.

Dr. Umeukeje's NPI, 1255579652, was assigned on January 23, 2009. Dr. Umeukeje holds Tennessee license 47016.

Dr. Umeukeje's primary practice is Vanderbilt Dialysis Clinic, at 3841 Green Hills Village Dr, Nashville, TN 37215 in Davidson County. The practice phone is (615) 936-3676.

Dr. Umeukeje's primary practice is Vanderbilt Dialysis Clinic in Nashville, Tennessee. Dr. Umeukeje is also affiliated with Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Umeukeje to 3 more hospitals, 2 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Umeukeje practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Umeukeje's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Umeukeje is licensed in Tennessee.

CMS data shows 248 Medicare services from Dr. Umeukeje across 6 procedure codes in 2024, for 121 Medicare patients. Medicare paid $18,477 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 121 Medicare patients who saw Dr. Umeukeje in 2024. The largest group is under 65, with 36 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 5.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Umeukeje's median patient age at 69, with 37% women.

In 2024, Dr. Umeukeje wrote 59 Medicare Part D claims for 23 patients. 83% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $1,719 in total drug cost. In 2022, CMS named 34 claims across 1 drug.

Dr. Umeukeje accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 35 papers to Dr. Umeukeje, published from 2014 to 2024. 2019 was the busiest year, with 5. The most frequent topics are Kidney Failure, Chronic, Renal Dialysis and Apolipoprotein L1. Dr. Umeukeje has published most often in Kidney Med. Dr. Umeukeje's most frequent co-authors are Kerri Lyn Cavanaugh, MD, Talat A. Ikizler, MD and Kausik Umanath, MD, MS.

CMS Open Payments shows 2 general payments to Dr. Umeukeje from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Travere Therapeutics, Inc. paid the most, $92.